Kenneth L. Horton
2012
In 2012, Kenneth L. Horton earned a total compensation of $2.8M as Former EVP & Chief Legal Officer at Vertex Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $169,260 |
|---|---|
| Option Awards | $1,822,615 |
| Salary | $259,327 |
| Stock Awards | $539,612 |
| Other | $11,921 |
| Total | $2,802,735 |
Horton received $1.8M in option awards, accounting for 65% of the total pay in 2012.
Horton also received $169.3K in non-equity incentive plan, $259.3K in salary, $539.6K in stock awards and $11.9K in other compensation.
Rankings
In 2012, Kenneth L. Horton's compensation ranked 2,502nd out of 11,487 executives tracked by ExecPay. In other words, Horton earned more than 78.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,502 out of 11,487 | 78th |
Division Manufacturing | 876 out of 4,253 | 79th |
Major group Chemicals And Allied Products | 197 out of 1,198 | 84th |
Industry group Drugs | 116 out of 920 | 87th |
Industry Pharmaceutical Preparations | 94 out of 700 | 87th |
Source: SEC filing on April 30, 2015.
Horton's colleagues
We found six more compensation records of executives who worked with Kenneth L. Horton at Vertex Pharmaceuticals in 2012.
2012
Matthew Emmens
Vertex Pharmaceuticals
Chief Executive Officer
2012
Jeffrey Leiden
Vertex Pharmaceuticals
Chief Executive Officer
2012
Stuart Arbuckle
Vertex Pharmaceuticals
EVP & Chief Commercial Officer
2012
Peter Mueller
Vertex Pharmaceuticals
Chief Scientific Officer
2012
David Howton
Vertex Pharmaceuticals
Chief Legal Officer
2012
Ian Smith
Vertex Pharmaceuticals